Physician profile
Robert Schonhoff
NPI 1568817005
$14,329.82
in general payments reported to CMS, 2019-2025
60 companies · $2,172 in 2025
The $2,172 reported for 2025 was more than what 92% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,734 · 2022: $3,394 · 2023: $2,543 · 2024: $2,487 · 2025: $2,172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,168 · Education: $33.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,168.43 |
| Education | $33.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,177.31 | 2021-2025 | Xarelto, Spravato |
| Novo Nordisk INC | $1,325.51 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,201.44 | 2021-2025 | |
| Lilly USA, LLC | $1,122.26 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals Lp | $706.94 | 2021-2025 | Airsupra, Fasenra, Breztri |
| Nevro Corp. | $617.78 | 2022-2024 | Senza |
| Glaxosmithkline, LLC. | $526.08 | 2021-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $514.06 | 2021-2025 | Jardiance, Synjardy, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $464.74 | 2021-2025 | |
| Corcept Therapeutics | $463.88 | 2021-2025 | Korlym |
| Amarin Pharma, INC. | $453.83 | 2021-2022 | |
| Amgen INC. | $445.02 | 2021-2025 | Evenity, Repatha |
| Inspire Medical Systems, INC. | $403.84 | 2023-2025 | Inspire |
| Astellas Pharma US INC | $301.95 | 2021-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $244.74 | 2021-2025 | Trintellix |
Show all 60 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $243.71 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $239.86 | 2021-2024 | |
| Axsome Therapeutics, INC. | $238.00 | 2024-2025 | Auvelity, Symbravo |
| Abbott Laboratories | $189.03 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Dexcom, INC. | $188.20 | 2024-2025 | Dexcom G6 Transmitter |
| Althera Pharmaceuticals LLC | $182.95 | 2021-2022 | |
| Edwards Lifesciences Corporation | $154.85 | 2023-2025 | Sapien 3 Ultra Resilia |
| Merck Sharp & Dohme LLC | $149.62 | 2021-2024 | Gardasil, Gardasil 9, Capvaxive |
| Stryker Corporation | $146.20 | 2025 | Mako |
| Intuity Medical INC | $142.22 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| E.R. Squibb & Sons, L.L.C. | $139.91 | 2022-2024 | Eliquis |
| Lexicon Pharmaceuticals, INC. | $131.66 | 2024 | |
| Si-Bone, INC. | $124.99 | 2021 | |
| Esperion Therapeutics, INC. | $121.24 | 2021-2024 | Nexletol |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.49 | 2022-2025 | Xifaxan |
| Sanofi-Aventis U.S. LLC | $66.51 | 2021-2025 | |
| Pfizer INC. | $61.31 | 2025 | |
| Radius Health, INC. | $51.94 | 2022 | |
| Exact Sciences Corporation | $49.22 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Tolmar, INC. | $48.90 | 2025 | Jatenzo |
| Corium, LLC | $48.70 | 2022 | |
| Eisai INC. | $47.93 | 2021 | |
| Sumitomo Pharma America, INC. | $41.32 | 2024-2025 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $39.16 | 2022 | |
| Boston Scientific Corporation | $38.74 | 2025 | Ams 700 |
| Alexion Pharmaceuticals, INC. | $32.65 | 2021-2025 | Strensiq |
| Kowa Pharmaceuticals America, INC. | $32.40 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $24.20 | 2021 | |
| Ardelyx, INC. | $24.02 | 2024 | Ibsrela |
| Madrigal Pharmaceuticals | $23.02 | 2025 | Rezdiffra |
| Arbor Pharmaceuticals, INC. | $21.26 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.90 | 2021 | |
| Halozyme INC | $18.73 | 2023 | |
| Idorsia Pharmaceuticals US INC | $18.62 | 2023 | Quviviq |
| Otsuka America Pharmaceutical, INC. | $17.98 | 2023 | Rexulti |
| Recordati_rare_diseases_inc. | $17.85 | 2024 | Isturisa, Signifor Lar |
| Ibsa Pharma INC. | $17.84 | 2023 | Tirosint, Licart |
| Averitas Pharma INC. | $17.27 | 2025 | Qutenza |
| Cequr Corporation | $15.88 | 2022 | |
| Mannkind Corporation | $15.39 | 2022 | |
| Phathom Pharmaceuticals, INC. | $15.00 | 2024 | Voquezna |
| Hikma Pharmaceuticals USA | $14.00 | 2023 | Kloxxado |
| Azurity Pharmaceuticals, INC. | $13.35 | 2023 | Edarbi |
| Medtronic, INC. | $13.15 | 2021 | |
| Genentech USA, INC. | $6.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schonhoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.